Trial Profile
Single versus double everolimus-eluting stent implantation in patients with true complex coronary bifurcation lesions.
Status:
Not stated
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2011
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- 05 May 2011 New trial record
- 05 Apr 2011 Results presented at the 60th Annual Scientific Session of the American College of Cardiology.